Related Experiment Video
Updated: Mar 8, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses
Yoon Jin Choi1, Nayoung Kim1,2, Hyuk Yoon1
1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, South Korea.
Bloating is a key risk factor for the overlap of functional dyspepsia (FD) and irritable bowel syndrome (IBS). Patients with postprandial distress syndrome face a higher risk of coexisting IBS, especially constipation-dominant IBS.
Area of Science:
- Gastroenterology
- Functional Gastrointestinal Disorders
- Genetics
Background:
- Functional dyspepsia (FD) and irritable bowel syndrome (IBS) are common gastrointestinal disorders.
- The overlap between FD and IBS (IBS-FD) and its associated risk factors are not well understood.
- Understanding these overlaps is crucial for effective diagnosis and management.
Purpose of the Study:
- To evaluate clinicodemographic features of FD, IBS, and IBS-FD overlap.
- To identify risk factors, including genetic polymorphisms, associated with IBS-FD.
- To clarify symptom profiles and prevalence in overlapping FD and IBS cases.
Main Methods:
- A study involving 632 subjects, including control, FD, IBS, and IBS-FD groups.
- Rome III criteria were used for diagnosing functional gastrointestinal disorders.
- Multivariate logistic regression analyzed risk factors, including 5-HTTLPR, ADRA2A, and CCK-1R genetic polymorphisms.
Main Results:
- IBS-FD overlap patients exhibited more severe symptoms (bloating, nausea, vomiting) and higher depression scores.
- Independent risk factors for IBS-FD included marital status, nausea, bloating, and incomplete emptying.
- Young age, depression, bloating, and postprandial distress syndrome were associated with IBS-FD in FD patients.
- 5-HTTLPR L/L genotype was a risk factor for co-occurring IBS with constipation (IBS-C) in FD patients.
Conclusions:
- Bloating is a significant risk factor for IBS-FD overlap.
- Postprandial distress syndrome increases the risk of coexisting IBS, particularly constipation-dominant IBS.
- Identifying specific risk factors aids in understanding and managing overlapping functional gastrointestinal disorders.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...

